Latest Prescription Drugs news
Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC
posted February 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
posted February 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
posted January 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Distribution of Opioid Meds Lower in Majority Non-White Communities
posted January 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain 
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing Monthly Specialist Briefings
Stay Connected
